Tag Archives: pharma

Recent and upcoming investment in Mexico

Information collected from media reports over the last month:

  • Automotive: U.S. automotive components supplier Android Industries inaugurated a new operations plant in the central state of Guanajuato. The US$21 million site is expected to put together kits of products such as spare tires, radiators, consoles and other parts for General Motors auto manufacturing plants.  (El Financiero, September 28, 2018)
  • Solar power: French energy conglomerate Engie announced it will construct a solar power generation plant in the northwestern state of Sonora. The US$111 million facility is projected to have generation capacity of 130.8 MW.  (Reforma, September 27, 2018)
  • OTC pharma: British-owned OTC medicines maker Sal de Uvas Picot plans approximately US$4.8 million in investment in Mexico manufacturing operations, the company reported. Resources will support a 20% expansion of production capacity for antacid products and cold medicines under the brands Sal de Uvas Picot and Mucinex.  (El Financiero, September 26, 2018)
  • Airlines: Mexican passenger air carrier Interjet will expand an existing aircraft order to Airbus for 20 more airplanes at a cost of approximately US$79 million, the company reported. The new A329 NEO aircraft will be phased into service over the coming five years. (El Financiero, September 17, 2018)
  • Liquor: S-Japanese drinks giant Beam Suntory has invested approximately US$60 million from 2017 through the present to modernize and expand its tequila plant in the western state of Jalisco, the company reported. Beam Suntory is launching a campaign to gain market share in the country for its traditional tequila brands Sauza and Hornitos. (El Financiero, September 12, 2018) Continue reading Recent and upcoming investment in Mexico

Mexico seeks entry into pharma practices agreement

PharmaMexico’s pharmaceutical industry has been performing well in recent years.  Both multinational subsidiaries and domestic manufacturers are targeting booming maladies like obesity and diabetes, and taking advantage of the relatively low cost of clinical testing and R&D.  But as private sector manufacturers make headlines investing in flashy new laboratories, The Mexican government has been quietly pursuing a regulatory initiative that may soon make an important impact on pharmaceutical manufacturing in the country. Continue reading Mexico seeks entry into pharma practices agreement